M

Microba Life Sciences Ltd
ASX:MAP

Watchlist Manager
Microba Life Sciences Ltd
ASX:MAP
Watchlist
Price: 0.096 AUD 12.94%
Market Cap: AU$58.5m

Relative Value

The Relative Value of one MAP stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.096 AUD, Microba Life Sciences Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MAP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

MAP Competitors Multiples
Microba Life Sciences Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Microba Life Sciences Ltd
ASX:MAP
51.8m AUD 3.7 -3.9 -2.5 -2.5
US
CVS Health Corp
NYSE:CVS
99.7B USD 0.3 212.5 14 14
US
Cigna Corp
NYSE:CI
77.7B USD 0.3 12.6 0 0
US
Cigna Group
XMUN:CGN
65.2B EUR 0.3 12.5 8 10.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.8B EUR 1.3 24.9 10.9 16.5
DE
Fresenius Medical Care AG
XMUN:FME
24B EUR 1.2 33.3 10.5 22.3
US
Laboratory Corporation of America Holdings
NYSE:LH
23.5B USD 1.7 27.4 14.7 20.5
US
Quest Diagnostics Inc
NYSE:DGX
23B USD 2.1 24.2 13 17.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.9B EUR 0.6 16.4 6.5 13.8
US
Guardant Health Inc
NASDAQ:GH
13.1B USD 14.6 -33 -34.8 -31.6
US
DaVita Inc
NYSE:DVA
10.2B USD 0.7 13.7 7.1 9.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
M
Microba Life Sciences Ltd
ASX:MAP
Average EV/EBITDA: 10.6
Negative Multiple: -2.5
N/A N/A
US
CVS Health Corp
NYSE:CVS
14
25%
0.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
8
4%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.9
14%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
10.5
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14.7
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
13
8%
1.6
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.5
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -34.8 N/A N/A
US
DaVita Inc
NYSE:DVA
7.1
5%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
M
Microba Life Sciences Ltd
ASX:MAP
Average EV/EBIT: 15.6
Negative Multiple: -2.5
N/A N/A
US
CVS Health Corp
NYSE:CVS
14
19%
0.7
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
10.1
5%
2
DE
Fresenius SE & Co KGaA
XETRA:FRE
16.5
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
22.3
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
20.5
27%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
17.6
11%
1.6
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.8
25%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -31.6 N/A N/A
US
DaVita Inc
NYSE:DVA
9.6
8%
1.2